Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Clinical trial NCT02567396 · WITHDRAWN

Trial details

NCT number: NCT02567396
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Estrogen Receptor Negative Head and Neck Squamous Cell Carcinoma HER2/Neu Negative Hormone-Resistant Prostate Cancer Metastatic Pancreatic Adenocarcinoma Progesterone Receptor Negative Solid Neoplasm Stage III Mesothelioma Stage IIIA Gastric Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIA Ovarian Cancer Stage IIIA Small Cell Lung Carcinoma

Start date: 2016-06-01
Primary completion: 2018-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.